IRIS
ASCARI, EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.531
AS - Asia 3.812
EU - Europa 3.098
SA - Sud America 420
AF - Africa 94
Continente sconosciuto - Info sul continente non disponibili 87
OC - Oceania 12
Totale 13.054
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.341
CN - Cina 2.045
SG - Singapore 794
IE - Irlanda 692
UA - Ucraina 470
HK - Hong Kong 370
FI - Finlandia 367
DE - Germania 350
BR - Brasile 318
RU - Federazione Russa 295
SE - Svezia 272
VN - Vietnam 248
IT - Italia 195
FR - Francia 165
GB - Regno Unito 163
IN - India 96
CA - Canada 91
ZA - Sudafrica 46
BD - Bangladesh 44
AR - Argentina 41
IQ - Iraq 25
NL - Olanda 25
JP - Giappone 24
BE - Belgio 19
PL - Polonia 18
ID - Indonesia 17
IR - Iran 17
MX - Messico 16
VE - Venezuela 16
CR - Costa Rica 15
ES - Italia 15
PK - Pakistan 15
CO - Colombia 13
EC - Ecuador 13
SA - Arabia Saudita 13
TR - Turchia 12
UZ - Uzbekistan 12
AU - Australia 11
JO - Giordania 10
MA - Marocco 10
NI - Nicaragua 10
GT - Guatemala 9
AT - Austria 8
DZ - Algeria 8
JM - Giamaica 8
KE - Kenya 8
MY - Malesia 8
PR - Porto Rico 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
HN - Honduras 7
PH - Filippine 7
PY - Paraguay 7
CW - ???statistics.table.value.countryCode.CW??? 6
DK - Danimarca 6
EG - Egitto 6
IL - Israele 6
SV - El Salvador 6
CL - Cile 5
NP - Nepal 5
AZ - Azerbaigian 4
EU - Europa 4
GR - Grecia 4
HR - Croazia 4
LB - Libano 4
PS - Palestinian Territory 4
RO - Romania 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
KZ - Kazakistan 3
LT - Lituania 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
GP - Guadalupe 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
ML - Mali 2
MM - Myanmar 2
MU - Mauritius 2
OM - Oman 2
RS - Serbia 2
SC - Seychelles 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
Totale 12.965
Salva come PNG Salva come JPEG
Città #
Dublin 689
Chandler 591
San Jose 585
Jacksonville 570
Nanjing 455
Ashburn 433
Singapore 398
Hong Kong 358
Beijing 296
Dallas 294
Council Bluffs 277
Boardman 209
Nanchang 191
Princeton 137
Shenyang 126
Hebei 125
Lawrence 125
Medford 121
Los Angeles 115
Changsha 114
Wilmington 113
Lauterbourg 104
Jiaxing 99
Helsinki 92
Ann Arbor 77
Ho Chi Minh City 77
Tianjin 74
Hangzhou 72
Munich 70
New York 66
Hanoi 58
Moscow 57
Buffalo 51
Milan 47
Shanghai 44
Redondo Beach 43
Santa Clara 41
Johannesburg 40
Turku 37
Woodbridge 33
Norwalk 28
São Paulo 28
Verona 26
Montreal 25
Chicago 24
Orem 23
Tokyo 23
Toronto 23
Seattle 20
Fairfield 19
Brussels 18
Houston 16
San Francisco 16
Atlanta 15
Denver 15
Guangzhou 15
Phoenix 15
Warsaw 15
Brooklyn 14
Haiphong 13
Kunming 13
Manchester 13
Da Nang 12
London 12
Rome 12
Boston 11
Chennai 11
Des Moines 11
Frankfurt am Main 11
Jinan 11
Zhengzhou 11
Brasília 10
Managua 10
The Dalles 10
Auburn Hills 9
Falkenstein 9
North Bergen 9
Poplar 9
Rio de Janeiro 9
San José 9
Tashkent 9
Baghdad 8
Guatemala City 8
Nairobi 8
Newark 8
Ningbo 8
Piscataway 8
Quito 8
San Genesio Ed Uniti 8
Taizhou 8
Amsterdam 7
Belo Horizonte 7
Cleveland 7
Columbus 7
Kingston 7
Mumbai 7
New Delhi 7
Palermo 7
Pittsburgh 7
Amman 6
Totale 8.257
Salva come PNG Salva come JPEG
Nome #
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 175
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 168
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 166
Acute promyelocitic leukemia toluidine blue subtype. 163
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 146
Anomalous erythrocytes produced by rabbits with liver damage. 144
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 144
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 143
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 141
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 137
AMYLOIDOSIS AL 135
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 135
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 135
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 135
Acute phase proteins and prognosis in multiple myeloma. 135
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 132
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 129
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 129
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 128
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 126
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 124
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 123
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 123
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 122
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 122
Acquired immune thrombastenia: a new bleeding disorder. 121
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 121
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 121
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 121
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 120
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 119
Possible evolution of human parvovirus B19 infection into erythroleukemia 119
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 119
Silymarine during maintenance therapy of acute promyelocytic leukemia. 118
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 115
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 115
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 114
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 113
Anemie megaloblastiche. 112
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 111
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 111
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 110
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 110
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 110
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 109
Changing clinical presentation of multiple myeloma. 109
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 108
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 107
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 106
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 104
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 104
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 104
[Chronic granulomatous disease with sea-blue histiocytosis: a case report (author's transl)]. 104
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure 104
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 103
Acute promyelocytic leukemia: morphological and clinical features. 103
Biologia e clinica del mieloma multiplo. 103
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 102
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 102
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 101
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 101
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 100
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 100
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 99
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 99
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 99
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 99
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 98
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 98
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 97
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 97
Fisiopatologia dell'eritrocito. 97
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 97
Chemotherapy-induced leukonychia 95
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 94
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 93
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 93
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 92
Glycopeptides of erythrocyte membranes in some hematological disorders 92
Applicazioni cliniche dei fattori di crescita emopoietici. 92
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 92
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 91
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 89
Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome. 89
Surface mechanisms of platelet adhesion and aggregation 88
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 88
Erythrocyte membrane modifications in chronic granulocytic leukaemia 86
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 86
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 86
Applicazioni cliniche della citometria. 86
Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study. 86
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 85
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 85
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 84
Immunocytochemical detection of factor XIII A--subunit in acute leukemia. 84
Loss of the Y chromosome in smoldering acute leukemia. 84
IL MIELOMA MULTIPLO 83
Biologic and clinical significance of red cell ferritin. 83
Terapia del mieloma multiplo. 83
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 82
Totale 10.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.165
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022609 0 0 0 0 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/20251.566 44 142 37 52 25 49 53 109 391 47 183 434
2025/20263.908 275 254 441 523 421 220 809 135 343 278 100 109
2026/2027979 81 195 227 463 13 0 0 0 0 0 0 0
Totale 13.054